Clinical and Experimental Effects of Reserpine in Patients with Essential Hypertension

Clinical and Experimental Effects of Reserpine in Patients with Essential Hypertension

Contributor(s):
Ari, Recep
Annals of the New York Academy of Sciences
Freis, Edward D.
Publication:
New York Academy of Sciences, 30 April 1954
Language(s):
English
Format:
Text
Subject(s):
Hypertension
Antihypertensive Agents
Reserpine
Genre(s):
Archival Materials
Articles
Abstract:
In this article, Freis and Ari presented the clinical data on their research for the ganglionic-blocking agent reserpine. They determined that it was ideal for treatment of mild hypertension, but because of its additive qualities, could be used in conjunction with other antihypertensive agents, such as hydralazine, for more severe cases.
Copyright:
This item may be under copyright protection; contact the copyright owner for permission before re-use.
Extent:
9 pages
NLM Unique ID:
101584929X45 (See in Profiles in Science)
Profiles in Science ID:
XFBBDD
Permanent Link:
http://resource.nlm.nih.gov/101584929X45
Archival Collection:
The Edward D. Freis Papers (Profiles in Science)